Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

Nature Genetics

Volumn 8, Issue 2, 1994, Pages 148-154

  Kaplitt, Michael G ^a,b   Leone, Paola ^a   Samulski, Richard J ^c   Xiao, Xiao ^d   Pfaff, Donald W ^b   O'Malley, Karen L ^e   During, Matthew J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d Merlin Pharmaceuticals ^*  (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TYROSINE 3 MONOOXYGENASE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CLONING VECTOR; CONTROLLED STUDY; CORPUS STRIATUM; GENE EXPRESSION; GENE TRANSFER; GLIA CELL; HELPER VIRUS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; VIRUS GENE;

ADENOVIRUSES, HUMAN; ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; BETA-GALACTOSIDASE; BRAIN; CORPUS STRIATUM; CYTOMEGALOVIRUS; DEPENDOVIRUS; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENES, REPORTER; GENES, SYNTHETIC; GENETIC VECTORS; HELPER VIRUSES; HUMANS; MALE; MICROINJECTIONS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SIMIAN VIRUS 40; SUBSTANTIA NIGRA; TRANSFECTION; TYROSINE 3-MONOOXYGENASE;

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; ANIMALIA; MAMMALIA; PARVOVIRUS;

EID: 0028169741     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1094-148     Document Type: Article

References (44)

1. Miller, D.G., Adam, M.A & Miller, A.D. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection.Molec. cell. biol. 10, 4329-4242 (1990).
2. Ho, D.Y. & Mocarski, E.S. B-galactosidase as a marker in the peripheral and neural tissues of the herpes-simplex virus-infected mouse. Virology167, 279-283 (1988).
3. Breakefield, X.O. & Deluka, N.A. Herpes simplex virus for gene delivery to neurons. New Biol. 3, 203-218 (1991).
4. Rotzman, B. & Jenklns, F.J. Genetic engineering of novel genomes of large DNA viruses. Science 229, 1208-1214 (1985).
5. Johnson, P.A. et al. Cytotoxicrty of a replication defective mutant of herpes simplex virus 1. J. Virol. 66, 2952-2955 (1992).
6. Le Gal La Salle, G. et al. An adenovirus vector for gene transfer into neruons and glia in the brain. Science 259, 988-990 (1993).
7. Akli, S. et al. Transfer of a foreign into the brain using adenovirus vectors. Nature Genetics 3, 224-228 (1993).
8. Davidson, B.L. et al. A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nature Genet. 3, 219-223 (1993).
9. Neve, R.L. Adenovirus vectors enter the brain. Trends Neurosci. 16, 251-253 (1993).
10. Spaete, R.R. & Frenkel, N. The herpes simplex virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector. Cell. 30, 295-304 (1982).
11. Kwong, A.D. & Frenkel, N. The herpes simplex virus amplicon IV. Effecient expression of a chimeric chicken ovalbumin gene amplified within defective virus genomes. Virology 142, 421-425 (1985).
12. Kaplitt, M.G. et al. Expression of afunctional foreign gene in adult mammalian brain following in vivo transfer viaaherpes simplex virus type 1 defective viral vector. Molec. cell. Neurosci. 2, 320-330 (1991).
13. Kaplitt, M.G. et al. Preproenkephalin promoter yields region-specific and long-term expression in adult brain following direct in vivo gene transfer via a defective herpes simplex viral vector. Proc. natn. Acad. Sci. U.S.A.19, 8979-8983 (1994).
14. Ho, D.Y., Mocarski, E.S. & Sapolsky, R.M. Altering central nervous system physiology with a defective herpes simplex virus vector expressing the glucose transporter gene. Proc. natn. Acad. Sci. USA. 90, 3655-3659 (1993).
15. Geller, A.I., Keyomarski, K., Bryan, J. & Pardee, A.B. An efficient deletion mutant packaging system for defective HSV-1 vectors; potential applications to neuronal physiology and human gene therapy. Proc. natn. Acad. Sci. U.S.A. 87, 8950-8954 (1990).
16. Bems, K.I. & Hauswirth, W.W. Adeno-associated viruses. Adv. Virus Res.26, 407-409 (1979).
17. Muzyczka, N. Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97-129 (1992).
18. Samulski, R.J., Chang, L.-S. & Shenk, T. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61, 3096-3101 (1987).
19. Samulski, R.J., Chang, L.-S. & Shenk, T. Helper-free stocks of adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63, 3022-3828 (1989).
20. Yahr, M.D. & Bergmann, K.J. (eds) Parkinson's disease. (Raven Press, New York, 1987).
21. Yatir, M.D. et al. Treatment of parkinsonism with levadopa. Arch. Neurol.21, 343-354 (1969).
22. Wolff, J.A. et al. Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson's Disease. Proc. natn. Acad. Sci. U.S.A.86, 9011-9014 (1989).
23. Freed, W.J. et al. Resoration of dopaminergic function by grafting of fetal rat substantia nigrato the caudate nucleus: long-term behavioral, biochemical, and histochemical studies. Ann. Neurol. 8, 510-519 (1987).
24. Horrelou, P. et al. In vivo release of dopa and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5, 393-402 (1990).
25. Jiao, S., Gurevich, V. & Wolff, J.A. Long term correction of rat model of Parkinson's Disease by gene therapy. Nature 262, 450-453 (1993).
26. Jones, N.C. & Shenk, T.S. Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13, 181-188 (1978).
27. Nuovo, G.J. et al. An improved technique for the in situ detection of DMA after polymerase chain reaction amplification. Am. J. Pathol. 139, 1239-1244, (1991).
28. Nuovo, G.J. et al. Importance of different variables for enhancing in situ detection of PCR-amplified DNA. PCR Meth. Appl. 2, 305-312 (1993).
29. Flotte, T.R. et al. Stable in vivo expression of the cystic fibrosistransmembrane conductance regulator with an adeno-associated virus vector. Proc. natn. Acad. Sci. U.S.A. 90, 10613-10617 (1993).
30. O'Malley, K.L. et al. Isolation and characterization of the human tyrosine hydroxylase gene: Identification of 5' alternative splice sites responsible for multiple mRNAs. Biochemistry 26, 6910-6914 (1987).
31. Dubach, M. et al. Primate neostriatal neurons containing tyrosine hydroxylase: immunohistochemical evidence. Neurosci. Lett. 75, 205-210 (1990).
32. Hefti, F., Melamed, E. & Wurtman, R.J. Partial lesions of the dopaminergic nigrostriatal system in rat brain: Biochemical characterization. Brain Res. 195, 123-127 (1980).
33. Margraves, R. & Freed, W.J. Chronic intrastriatal dopamine infusions in rats with unilateral lesions of the substantia nigra. Life Sci. 40, 959-966 (1987).
34. Freed, W.J. et al. Resoration of dopaminergic function by grafting of fetal rat substantia nigra to the caudate nucleus: long-term behavioral, biochemical, and histochemical studies. Ann. Neurol. 8, 510-519 (1987).
35. Lebkowski, J.S., McNally, M.M., Okarma, T.B. & Lerch, L.B. Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Molec. cell. Biol. 8, 3988-3996 (1988).
36. Scharfmann, R., Axelrod, J.H. & Verma, I.M. Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. natn. Acad. Sci. U.S.A. 88, 4626-4630 (1991).
37. Samulski, R.J. et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10, 3941-3950 (1991).
38. McLaughlin, S.K. et al. Adeno-associated virus general transduction vectors: Analysis of proviral structures. J. Virol. 62, 1963-1973 (1988).
39. Poole, S. et al. Gene transfer into hematopoietic stem cells using AAV vectors: targeted integration into chromosome 19. Blood. (in the press).
40. Graham, F.L. & van der Eb, A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52, 456-467 (1973).
41. Graham, F.L., Smiley, J., Russell, W.C. & Nairn, R. Characterization of a human cell line transformed by DNA from human adenovirus type 5. J. gen. Virol. 36, 59-74 (1977).
42. Paxinos, G. & Watson, C. The rat brain in stereotaxic coordinates. (Academic Press, Australia, 1982).
43. Perese, D.A., Ulman, J., Viola, J., Ewing, S.E. & Bankiewicz, K.S. A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res.494, 285-293 (1989).
44. During, M.J. et al. Biochemical and behavioral recovery in a rodent model of Parkinson's Disease following stereotactic implantation of dopamine-containing liposomes. Exp. Neurol. 115, 193-199 (1992).